Cargando…
In Vitro Metabolite Profiling of ADB-FUBINACA, A New Synthetic Cannabinoid
Metabolite profiling of novel psychoactive substances (NPS) is critical for documenting drug consumption. N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (ADB-FUBINACA) is an emerging synthetic cannabinoid whose toxicological and metabolic data are currently una...
Autores principales: | Carlier, Jeremy, Diao, Xingxing, Wohlfarth, Ariane, Scheidweiler, Karl, Huestis, Marilyn A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771045/ https://www.ncbi.nlm.nih.gov/pubmed/29403341 http://dx.doi.org/10.2174/1570159X15666161108123419 |
Ejemplares similares
-
Overview of Synthetic Cannabinoids ADB-FUBINACA and AMB-FUBINACA: Clinical, Analytical, and Forensic Implications
por: Lobato-Freitas, Carolina, et al.
Publicado: (2021) -
Strategies to distinguish new synthetic cannabinoid FUBIMINA (BIM-2201) intake from its isomer THJ-2201: metabolism of FUBIMINA in human hepatocytes
por: Diao, Xingxing, et al.
Publicado: (2016) -
New Synthetic Cannabinoids Metabolism and Strategies to Best Identify Optimal Marker Metabolites
por: Diao, Xingxing, et al.
Publicado: (2019) -
Pyrrolidinyl Synthetic Cathinones α-PHP and 4F-α-PVP Metabolite Profiling Using Human Hepatocyte Incubations
por: Carlier, Jeremy, et al.
Publicado: (2020) -
The short-acting synthetic cannabinoid AB-FUBINACA induces physical dependence in mice
por: Trexler, Kristen R., et al.
Publicado: (2020)